Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAD2L1 |
| Upstream (Parents) |
|---|
| (<<) CCNA2 → MAD2L1 |
| (<<) FH → MAD2L1 |
| (<<) ANLN → MAD2L1 |
| (<<) UBE2T → MAD2L1 |
| (<<) BIRC5 → MAD2L1 |
| Downstream (Children) |
|---|
| MAD2L1 → PAICS (>>) |
| MAD2L1 → OSGIN2 (>>) |
| MAD2L1 → RAD18 (>>) |
| MAD2L1 → TXLNG (>>) |
| MAD2L1 → CDKN3 (>>) |
| MAD2L1 → TMEM194A (>>) |
| MAD2L1 → CCNA2 (>>) |
| MAD2L1 → ANLN (>>) |
| MAD2L1 → RRM1 (>>) |
| MAD2L1 → GART (>>) |
| MAD2L1 → ZWILCH (>>) |
| MAD2L1 → MRPL50 (>>) |
| MAD2L1 → UBE2T (>>) |
| MAD2L1 → HADH (>>) |
| MAD2L1 → LAPTM4B (>>) |
| MAD2L1 → UBE2S (>>) |
| MAD2L1 → RFC3 (>>) |
| MAD2L1 → BIRC5 (>>) |
| MAD2L1 → ME2 (>>) |
| MAD2L1 → NUSAP1 (>>) |
